696 related articles for article (PubMed ID: 33141149)
1. Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study.
Charlier S; Vavanikunnel J; Becker C; Jick SS; Meier C; Meier CR
J Clin Endocrinol Metab; 2021 Jan; 106(2):554-566. PubMed ID: 33141149
[TBL] [Abstract][Full Text] [Related]
2. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
Losada E; Soldevila B; Ali MS; Martínez-Laguna D; Nogués X; Puig-Domingo M; Díez-Pérez A; Mauricio D; Prieto-Alhambra D
Osteoporos Int; 2018 Sep; 29(9):2079-2086. PubMed ID: 29860664
[TBL] [Abstract][Full Text] [Related]
3. Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study.
Vavanikunnel J; Charlier S; Becker C; Schneider C; Jick SS; Meier CR; Meier C
J Clin Endocrinol Metab; 2019 May; 104(5):1645-1654. PubMed ID: 30657918
[TBL] [Abstract][Full Text] [Related]
4. Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south west Ethiopia: a case control study.
Mamo Y; Bekele F; Nigussie T; Zewudie A
BMC Endocr Disord; 2019 Aug; 19(1):91. PubMed ID: 31464602
[TBL] [Abstract][Full Text] [Related]
5. Metformin plus a low hypoglycemic risk antidiabetic drug vs. metformin monotherapy for untreated type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
Hung WT; Chen YJ; Cheng CY; Ovbiagele B; Lee M; Hsu CY
Diabetes Res Clin Pract; 2022 Jul; 189():109937. PubMed ID: 35662614
[TBL] [Abstract][Full Text] [Related]
6. Association of diabetes treatment with long-term glycemic patterns in patients with type 2 diabetes mellitus: A prospective cohort study.
Luo M; Tan CS; Lim WY; Chia KS; Tang WE; Tai ES; Venkataraman K
Diabetes Metab Res Rev; 2019 May; 35(4):e3122. PubMed ID: 30600922
[TBL] [Abstract][Full Text] [Related]
7. Predictors of poor glycemic control among type 2 diabetes mellitus patients treated with antidiabetic medications: A cross-sectional study in China.
Wang J; Li J; Wen C; Liu Y; Ma H
Medicine (Baltimore); 2021 Oct; 100(43):e27677. PubMed ID: 34713865
[TBL] [Abstract][Full Text] [Related]
8. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.
Au Yeung SL; Schooling CM
BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803
[TBL] [Abstract][Full Text] [Related]
9. Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study.
Koye DN; Montvida O; Paul SK
Drugs; 2020 Apr; 80(5):477-487. PubMed ID: 32141024
[TBL] [Abstract][Full Text] [Related]
10. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.
Huri HZ; Lim LP; Lim SK
Drug Des Devel Ther; 2015; 9():4355-71. PubMed ID: 26300627
[TBL] [Abstract][Full Text] [Related]
11. Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study.
Borgharkar SS; Das SS
BMJ Open Diabetes Res Care; 2019; 7(1):e000654. PubMed ID: 31413840
[TBL] [Abstract][Full Text] [Related]
12. Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes.
Abdelgani S; Puckett C; Adams J; Triplitt C; DeFronzo RA; Abdul-Ghani M
J Clin Endocrinol Metab; 2021 Nov; 106(12):3497-3504. PubMed ID: 34343296
[TBL] [Abstract][Full Text] [Related]
13. A statistical model to identify determinants of glycemic control in patients with type 2 diabetes with different pharmacotherapeutic profiles.
Moura AM; Antunes M; Martins SO; Raposo JF
PLoS One; 2020; 15(7):e0235376. PubMed ID: 32629460
[TBL] [Abstract][Full Text] [Related]
14. Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study.
R Charlier SH; Meier C; Jick SS; Meier CR; Becker C
Cardiovasc Diabetol; 2022 Jan; 21(1):2. PubMed ID: 34983504
[TBL] [Abstract][Full Text] [Related]
15. Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study.
Fu AZ; Qiu Y; Radican L; Yin DD; Mavros P
Cardiovasc Diabetol; 2010 Apr; 9():15. PubMed ID: 20409333
[TBL] [Abstract][Full Text] [Related]
16. Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital.
Ayele AA; Tegegn HG; Ayele TA; Ayalew MB
BMJ Open Diabetes Res Care; 2019; 7(1):e000685. PubMed ID: 31321061
[TBL] [Abstract][Full Text] [Related]
17. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
18. Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.
Tao T; Wu P; Wang Y; Liu W
BMC Endocr Disord; 2018 Feb; 18(1):14. PubMed ID: 29482528
[TBL] [Abstract][Full Text] [Related]
19. Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study.
Zhang B; Zhao J; Yang W;
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667797
[TBL] [Abstract][Full Text] [Related]
20. Understanding of antidiabetic medication is associated with blood glucose in patients with type 2 diabetes: At baseline date of the KAMOGAWA-DM cohort study.
Sakai R; Hashimoto Y; Ushigome E; Okamura T; Hamaguchi M; Yamazaki M; Oda Y; Fukui M
J Diabetes Investig; 2019 Mar; 10(2):458-465. PubMed ID: 30136448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
